Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach

被引:5
作者
Al Natour, Riad H. [1 ]
Catanzaro, A. [2 ]
Zolotarevsky, E. [2 ]
DeBenedet, Anthony T. [2 ]
Gunaratnam, Naresh T. [2 ]
机构
[1] St Joseph Mercy Hlth Syst, Surg Dept, 5333 McAuley Dr,Suite RHB-2115, Ann Arbor, MI 48197 USA
[2] St Joseph Mercy Hlth Syst, Huron Gastro Ctr Digest Dis, 5300 Elliott Dr, Ann Arbor, MI 48197 USA
关键词
ablation; Barrett's esophagus; endoscopic mucosal resection; esophageal adenocarcinoma; radiofrequency; RADIOFREQUENCY ABLATION; EARLY NEOPLASIA; ADENOCARCINOMA; RESECTION; SURVEILLANCE; MANAGEMENT; OUTCOMES; REGISTRY; TRIAL;
D O I
10.1093/dote/dox126
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Barrett's esophagus with high-grade dysplasia (BEHGD) and intramucosal esophageal adenocarcinoma (IMC) can be treated by radiofrequency ablation (RFA) and endoscopic mucosal resection (EMR). Efficacy of RFA and EMR in academic medical centers has been demonstrated in previous studies. However, the clinical effectiveness of this approach in community clinical practice is not fully established. All patients with biopsy-proven BEHGD and IMC (T1a), who were treated endoscopically between 2007 and 2014, were prospectively enrolled. Treatment algorithms were determined by consensus opinion after presentation at gastrointestinal tumor board. Patients underwent EMR and/or RFA until eradication-of-dysplasia and complete remission of intestinal metaplasia (CRIM) was achieved. Patients were then enrolled in an endoscopic surveillance program. A total of 60 patients underwent endoscopic therapy for BEHGD (32) or IMC (28). Median length BE was 4 cm. Forty-six patients had EMR. Median treatment interval was nine months. Median follow-up was 33 months (Interquartile range: 16-50). Fifty-five (92%) patients achieved eradication-of-dysplasia and 52(87%) CRIM. One patient with BEHGD did not achieve any benefit six months into treatment. Nine (15%) patients relapsed after CRIM with nondysplastic-BE (6), BE with low-grade dysplasia (1), and BEHGD (2). After retreatment, eradication-of-intestinal metaplasia was achieved in five patients. BE length was a negative predictor for achieving CRIM (OR 0.81; P = 0.04). There were no procedure-related severe complications. Eleven patients with prior EMR developed symptomatic strictures, which were all successfully dilated. Endoscopic management of BEHGD and IMC can be safely and effectively performed in a community clinical practice similarly to high-volume academic medical centers when performed by advanced endoscopists following multidisciplinary approach.
引用
收藏
页数:6
相关论文
共 18 条
[1]   Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process [J].
Bennett, Cathy ;
Vakil, Nimish ;
Bergman, Jacques ;
Harrison, Rebecca ;
Odze, Robert ;
Vieth, Michael ;
Sanders, Scott ;
Gay, Laura ;
Pech, Oliver ;
Longcroft-Wheaton, Gaius ;
Romero, Yvonne ;
Inadomi, John ;
Tack, Jan ;
Corley, Douglas A. ;
Manner, Hendrik ;
Green, Susi ;
Al Dulaimi, David ;
Ali, Haythem ;
Allum, Bill ;
Anderson, Mark ;
Curtis, Howard ;
Falk, Gary ;
Fennerty, M. Brian ;
Fullarton, Grant ;
Krishnadath, Kausilia ;
Meltzer, Stephen J. ;
Armstrong, David ;
Ganz, Robert ;
Cengia, Gianpaolo ;
Going, James J. ;
Goldblum, John ;
Gordon, Charles ;
Grabsch, Heike ;
Haigh, Chris ;
Hongo, Michio ;
Johnston, David ;
Forbes-Young, Ricky ;
Kay, Elaine ;
Kaye, Philip ;
Lerut, Toni ;
Lovat, Laurence B. ;
Lundell, Lars ;
Mairs, Philip ;
Shimoda, Tadakuza ;
Spechler, Stuart ;
Sontag, Stephen ;
Malfertheiner, Peter ;
Murray, Iain ;
Nanji, Manoj ;
Poller, David .
GASTROENTEROLOGY, 2012, 143 (02) :336-346
[2]   Safety and Efficacy of Endoscopic Mucosal Therapy With Radiofrequency Ablation for Patients With Neoplastic Barrett's Esophagus [J].
Bulsiewicz, William J. ;
Kim, Hannah P. ;
Dellon, Evan S. ;
Cotton, Cary C. ;
Pasricha, Sarina ;
Madanick, Ryan D. ;
Spacek, Melissa B. ;
Bream, Susan E. ;
Chen, Xiaoxin ;
Orlando, Roy C. ;
Shaheen, Nicholas J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (06) :636-642
[3]   The Risk of Lymph-Node Metastases in Patients With High-Grade Dysplasia or Intramucosal Carcinoma in Barrett's Esophagus: A Systematic Review [J].
Dunbar, Kerry B. ;
Spechler, Stuart Jon .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (06) :850-862
[4]   Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry [J].
Haidry, R. J. ;
Butt, M. A. ;
Dunn, J. M. ;
Gupta, A. ;
Lipman, G. ;
Smart, H. L. ;
Bhandari, P. ;
Smith, L. ;
Willert, R. ;
Fullarton, G. ;
Di Pietro, M. ;
Gordon, C. ;
Penman, I. ;
Barr, H. ;
Patel, P. ;
Kapoor, N. ;
Hoare, J. ;
Narayanasamy, R. ;
Ang, Y. ;
Veitch, A. ;
Ragunath, K. ;
Novelli, M. ;
Lovat, L. B. .
GUT, 2015, 64 (08) :1192-1199
[5]   Radiofrequency Ablation and Endoscopic Mucosal Resection for Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma: Outcomes of the UK National Halo RFA Registry [J].
Haidry, Rehan J. ;
Dunn, Jason M. ;
Butt, Mohammed A. ;
Burnell, Matthew G. ;
Gupta, Abhinav ;
Green, Sarah ;
Miah, Haroon ;
Smart, Howard L. ;
Bhandari, Pradeep ;
Smith, Lesley Ann ;
Willert, Robert ;
Fullarton, Grant ;
Morris, John ;
Di Pietro, Massimo ;
Gordon, Charles ;
Penman, Ian ;
Barr, Hugh ;
Patel, Praful ;
Boger, Philip ;
Kapoor, Neel ;
Mahon, Brinder ;
Hoare, Jonathon ;
Narayanasamy, Ravi ;
O'Toole, Dermot ;
Cheong, Edward ;
Direkze, Natalie C. ;
Ang, Yeng ;
Novelli, Marco ;
Banks, Matthew R. ;
Lovat, Laurence Bruce .
GASTROENTEROLOGY, 2013, 145 (01) :87-95
[6]   Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II) [J].
Phoa, K. Nadine ;
Pouw, Roos E. ;
Bisschops, Raf ;
Pech, Oliver ;
Ragunath, Krish ;
Weusten, Bas L. A. M. ;
Schumacher, Brigitte ;
Rembacken, Bjorn ;
Meining, Alexander ;
Messmann, Helmut ;
Schoon, Erik J. ;
Gossner, Liebwin ;
Mannath, Jayan ;
Seldenrijk, C. A. ;
Visser, Mike ;
Lerut, Toni ;
Seewald, Stefan ;
ten Kate, Fiebo J. ;
Ell, Christian ;
Neuhaus, Horst ;
Bergman, Jacques J. G. H. M. .
GUT, 2016, 65 (04) :555-562
[7]   Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade Dysplasia A Randomized Clinical Trial [J].
Phoa, K. Nadine ;
van Vilsteren, Frederike G. I. ;
Weusten, Bas L. A. M. ;
Bisschops, Raf ;
Schoon, Erik J. ;
Ragunath, Krish ;
Fullarton, Grant ;
Di Pietro, Massimiliano ;
Ravi, Narayanasamy ;
Visser, Mike ;
Offerhaus, G. Johan ;
Seldenrijk, Cees A. ;
Meijer, Sybren L. ;
ten Kate, Fiebo J. W. ;
Tijssen, Jan G. P. ;
Bergman, Jacques J. G. H. M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (12) :1209-1217
[8]   Remission of Barrett's Esophagus With Early Neoplasia 5 Years After Radiofrequency Ablation With Endoscopic Resection: A Netherlands Cohort Study [J].
Phoa, K. Nadine ;
Pouw, Roos E. ;
Van Vilsteren, Frederike G. I. ;
Sondermeijer, Carine M. T. ;
Ten Kate, Fiebo J. W. ;
Visser, Mike ;
Meijer, Sybren L. ;
Henegouwen, Mark I. Van Berge ;
Weusten, Bas L. A. M. ;
Schoon, Erik J. ;
Mallant-Hent, Rosalie C. ;
Bergman, Jacques J. G. H. M. .
GASTROENTEROLOGY, 2013, 145 (01) :96-104
[9]   The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence [J].
Pohl, H ;
Welch, HG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (02) :142-146
[10]   Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection [J].
Pouw, Roos E. ;
Gondrie, Joep J. ;
Sondermeijer, Carine M. ;
ten Kate, Fiebo J. ;
van Gulik, Thomas M. ;
Krishnadath, Kausilia K. ;
Fockens, Paul ;
Weusten, Bas L. ;
Bergman, Jacques J. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (10) :1627-1636